KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to -$390.5 million.

  • Globus Medical's Enterprise Value rose 4378.59% to -$390.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$390.5 million, marking a year-over-year increase of 4378.59%. This contributed to the annual value of -$890.1 million for FY2024, which is 7189.57% down from last year.
  • Latest data reveals that Globus Medical reported Enterprise Value of -$390.5 million as of Q3 2025, which was up 4378.59% from -$229.4 million recorded in Q2 2025.
  • Over the past 5 years, Globus Medical's Enterprise Value peaked at -$229.4 million during Q2 2025, and registered a low of -$890.1 million during Q4 2024.
  • Moreover, its 5-year median value for Enterprise Value was -$461.3 million (2025), whereas its average is -$489.0 million.
  • As far as peak fluctuations go, Globus Medical's Enterprise Value plummeted by 7189.57% in 2024, and later skyrocketed by 5345.29% in 2025.
  • Globus Medical's Enterprise Value (Quarter) stood at -$443.4 million in 2021, then fell by 0.59% to -$446.1 million in 2022, then dropped by 16.08% to -$517.8 million in 2023, then plummeted by 71.9% to -$890.1 million in 2024, then surged by 56.12% to -$390.5 million in 2025.
  • Its Enterprise Value stands at -$390.5 million for Q3 2025, versus -$229.4 million for Q2 2025 and -$461.3 million for Q1 2025.